0.00
Schlusskurs vom Vortag:
$7.04
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$1.08B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.12M
KGV:
0.00
EPS:
-4.8149
Netto-Cashflow:
$-2.69M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
180 Life Sciences Corp Stock (ATNF) Company Profile
Firmenname
180 Life Sciences Corp
Sektor
Branche
Telefon
650-507-0669
Adresse
3000 EL CAMINO REAL, PALO ALTO
Vergleichen Sie ATNF mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
400.29 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
455.36 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
581.90 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
741.45 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
322.34 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-09-15 | Eingeleitet | Maxim Group | Buy |
180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten
Smart tools for monitoring 180 Life Sciences Corp.’s price actionTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser
Can 180 Life Sciences Corp. deliver consistent dividendsVolume Spike & Free Reliable Trade Execution Plans - khodrobank.com
Price momentum metrics for 180 Life Sciences Corp. explained2025 Volatility Report & Safe Capital Growth Stock Tips - Newser
What is 180 Life Sciences Corp.’s book value per shareRisk Management & Accurate Trade Setup Notifications - khodrobank.com
How sensitive is 180 Life Sciences Corp. Equity Warrant to inflation2025 Market Sentiment & AI Driven Price Predictions - khodrobank.com
Published on: 2025-09-03 06:12:15 - Newser
Real time scanner hits for 180 Life Sciences Corp. Equity Warrant explained2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
How to use Fibonacci retracement on 180 Life Sciences Corp. Equity WarrantQuarterly Growth Report & Low Drawdown Trading Strategies - Newser
Is 180 Life Sciences Corp. stock good for income investorsQuarterly Portfolio Summary & Growth Focused Entry Point Reports - khodrobank.com
What data driven models say about 180 Life Sciences Corp. Equity Warrant’s futureTrend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-03 02:38:04 - Newser
180 Life Sciences Corp. stock outlook for YEARNew Guidance & Long-Term Safe Investment Plans - Newser
Will 180 Life Sciences Corp. Equity Warrant outperform the marketMarket Movers & Low Drawdown Momentum Ideas - Newser
Will 180 Life Sciences Corp. price bounce be sustainableM&A Rumor & Short-Term High Return Strategies - Newser
Analyzing 180 Life Sciences Corp. Equity Warrant with risk reward ratio chartsMarket Trend Report & Weekly High Conviction Trade Ideas - Newser
Detecting support and resistance levels for 180 Life Sciences Corp. Equity Warrant2025 Retail Activity & Real-Time Price Movement Reports - Newser
Should you hold or exit 180 Life Sciences Corp. Equity Warrant nowMarket Sentiment Report & High Accuracy Swing Entry Alerts - Newser
What does recent volatility data suggest for 180 Life Sciences Corp.Market Risk Analysis & Smart Allocation Stock Reports - Newser
Is 180 Life Sciences Corp. Equity Warrant forming a bottoming base2025 Sector Review & Daily Oversold Bounce Ideas - Newser
Real time social sentiment graph for 180 Life Sciences Corp.2025 Macro Impact & Daily Volume Surge Signals - Newser
Analyzing drawdowns of 180 Life Sciences Corp. with statistical toolsJuly 2025 Reactions & High Yield Stock Recommendations - Newser
Multi asset correlation models including 180 Life Sciences Corp.Share Buyback & Stock Portfolio Risk Management - Newser
Is 180 Life Sciences Corp. part of any ETFNew Guidance & Accurate Trade Setup Notifications - khodrobank.com
What indicators show strength in 180 Life Sciences Corp.Market Risk Analysis & Real-Time Stock Entry Alerts - Newser
What are 180 Life Sciences Corp.’s recent SEC filings showingRisk Management & Free Growth Oriented Trading Recommendations - khodrobank.com
Is it time to cut losses on 180 Life Sciences Corp. Equity WarrantChart Signals & High Win Rate Trade Alerts - Newser
Is 180 Life Sciences Corp. Equity Warrant stock poised for growthExit Point & Consistent Return Investment Signals - Newser
Regression analysis insights on 180 Life Sciences Corp. Equity Warrant performanceWeekly Loss Report & Low Drawdown Investment Ideas - Newser
How does 180 Life Sciences Corp. Equity Warrant perform in inflationary periods2025 Risk Factors & Real-Time Chart Breakout Alerts - khodrobank.com
How cyclical is 180 Life Sciences Corp. Equity Warrant’s revenue streamProfit Target & Low Risk High Reward Trade Ideas - خودرو بانک
Visual trend scoring systems applied to 180 Life Sciences Corp. Equity WarrantWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Using data tools to time your 180 Life Sciences Corp. exitJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
What analysts say about 180 Life Sciences Corp. stock2025 Buyback Activity & Real-Time Buy Zone Alerts - خودرو بانک
Volume spikes in 180 Life Sciences Corp. stock – what they meanJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
Developing predictive dashboards with 180 Life Sciences Corp. data2025 Short Interest & Real-Time Volume Triggers - Newser
Is it too late to sell 180 Life Sciences Corp. Equity WarrantMarket Risk Analysis & High Return Stock Watch Alerts - Newser
Risk Recap: Can 180 Life Sciences Corp. Equity Warrant reach resistance levels soonJuly 2025 Highlights & Low Risk Growth Stock Ideas - khodrobank.com
180 Life Sciences Corp. Equity Warrant stock trendline breakdown2025 Support & Resistance & Risk Managed Investment Strategies - Newser
Technical analysis overview for 180 Life Sciences Corp. Equity Warrant stockQuarterly Trade Review & AI Forecast for Swing Trade Picks - Newser
Aug PreEarnings: What’s next for 180 Life Sciences Corp. stockJuly 2025 Chart Watch & Free Growth Oriented Trading Recommendations - khodrobank.com
Momentum Traders Eye 180 Life Sciences Corp. for Quick Bounce getLinesFromResByArray error: size == 0 - thegnnews.com
Can 180 Life Sciences Corp. Equity Warrant hit a new high this monthQuarterly Portfolio Review & High Conviction Buy Zone Alerts - Newser
Published on: 2025-09-01 20:54:44 - Newser
What’s next for 180 Life Sciences Corp. stock2025 Valuation Update & Daily Growth Stock Tips - khodrobank.com
What technical models suggest about 180 Life Sciences Corp. Equity Warrant’s comebackJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Is 180 Life Sciences Corp. Equity Warrant in a bullish channelJuly 2025 News Drivers & Fast Moving Stock Watchlists - خودرو بانک
How do insiders feel about 180 Life Sciences Corp.Weekly Market Report & Entry Point Strategy Guides - خودرو بانک
180 Life Sciences Corp. stock trend outlook and recovery pathJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
Is this a good reentry point in 180 Life Sciences Corp. Equity WarrantTrade Ideas & Safe Capital Preservation Plans - Newser
Understanding 180 Life Sciences Corp. Equity Warrant’s price movementLong Setup & Expert Verified Movement Alerts - Newser
Published on: 2025-09-01 12:42:53 - Newser
Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)
Umsatz
Nettogewinn
Free Cashflow
ENV
180 Life Sciences Corp-Aktie (ATNF) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 08 '25 |
Sale |
3.18 |
777,595 |
2,472,752 |
1,725,148 |
ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 11 '25 |
Sale |
3.17 |
405,148 |
1,284,319 |
1,320,000 |
ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 07 '25 |
Sale |
3.56 |
135,257 |
481,515 |
2,502,743 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):